obio: the cashflow

MyFinsight

obio: the cashflow

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Purchases of marketable securities	50,683	2,902
Net cash (used in) provided by investing activities	-9,229	29,355
Proceeds from sale of common stock and pre-funded warrants, net of issuance costs	57,780	-
Proceeds from the royalty purchase agreement	20,000	-
Proceeds from exercise of stock options	91	91
Restricted stock units withheld for tax	1,084	815
Deferred financing costs - royalty purchase agreement	1,114	-
Net cash provided by financing activities	75,673	-724
Net increase (decrease) in cash and cash equivalents	19,751	-3,512
Cash and cash equivalents at beginning of period	22,261	-
Cash and cash equivalents at end of period	42,012	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.